Advancing Access to HIV/HCV Testing for People Who Inject Drugs (PWID)
Recruiting · NCT06730555 · Interventional (participants receive a specific treatment) · Lead sponsor: University of Miami
View the official record on ClinicalTrials.gov →Interventions studied
ACCESS InterventionControl Group
What this trial is about
The purpose of this study is to test the effectiveness of the ACCESS strategy: an organizational-level intervention that uses funding and practice facilitation to improve the organizational capacity of syringe services programs (SSPs) to implement routine, opt-out HIV and Hepatitis C (HCV) testing and linkage to care for people who inject drugs (PWID).
Who can take part
Age range
18 Years and older
Sex
All (male and female)
Healthy volunteers
Yes - healthy volunteers may be accepted
Phase
Not applicable (e.g. observational or device study)
Study type
Interventional (participants receive a specific treatment)
Inclusion criteria
- SSPs must:
- be operating in an Ending the HIV Epidemic (EHE) or Centers for Disease Control and Prevention (CDC) determined vulnerable jurisdictions;
- serve at least 300 unique participants per year;
- not currently offer opt-out HIV/HCV testing;
- be capable and willing to prospectively collect aggregated, site-level data on the number of participants who are: i) offered HIV/HCV screening, ii) completed these tests, and iii) linked to care, as well as provide participant demographics;
- have key staff that consent to participate in study surveys, qualitative interviews and practice facilitation throughout the study.
Exclusion criteria
- SSPs must not:
- currently receive or have received Frontline Communities in the United States (FOCUS) funding;
- have already implemented opt-out HIV/HCV testing.
- currently participating in SAIA-SSP-HIV (NCT06025435)
Where it is running
1 location listed across 1 US state.
- University of Miami - Miami, Florida, United States